We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$21.1M
Cap. Flow
+$10.8M
Cap. Flow %
0.83%
Top 10 Hldgs %
44%
Holding
310
New
3
Increased
19
Reduced
69
Closed
48

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$24M
2
AXP icon
American Express
AXP
+$1.73M
3
NVDA icon
NVIDIA
NVDA
+$1.56M
4
SOLS
Solstice Advanced Materials
SOLS
+$1.34M
5
Q
Qnity Electronics Inc
Q
+$394K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.76M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.74M
3
HON icon
Honeywell
HON
+$1.53M
4
MA icon
Mastercard
MA
+$1.22M
5
JPM icon
JPMorgan Chase
JPM
+$1.19M

Sector Composition

Rank Sector Weight
1 Industrials 21.18%
2 Financials 20.56%
3 Technology 18.47%
4 Consumer Discretionary 15.51%
5 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFLX icon
101
Netflix
NFLX
$292B
$309K 0.02%
3,300
-100
-3% -$10.8K
BALL icon
102
Ball Corp
BALL
$17B
$279K 0.02%
5,265
– –
CL icon
103
Colgate-Palmolive
CL
$72.6B
$277K 0.02%
3,500
– –
EVRG icon
104
Evergy
EVRG
$20.1B
$271K 0.02%
3,734
-297
-7% -$22.5K
TXN icon
105
Texas Instruments
TXN
$255B
$260K 0.02%
1,500
– –
BRK.B icon
106
Berkshire Hathaway Class B
BRK.B
$1.07T
$251K 0.02%
500
– –
ASH icon
107
Ashland
ASH
$3.04B
$245K 0.02%
4,182
-546
-12% -$28.9K
REGN icon
108
Regeneron Pharmaceuticals
REGN
$68.8B
$242K 0.02%
314
+260
+481% +$177K
FMS icon
109
Fresenius Medical Care
FMS
$13.2B
$232K 0.02%
9,734
– –
KWR icon
110
Quaker Houghton
KWR
$2.63B
$217K 0.02%
1,582
– –
EXAS
111
DELISTED
Exact Sciences
EXAS
$203K 0.02%
1,997
– –
ENB icon
112
Enbridge
ENB
$124B
$202K 0.02%
4,220
– –
BNY
113
Bank of New York Mellon
BNY
$108B
$197K 0.02%
1,700
– –
GH icon
114
Guardant Health
GH
$19.5B
$194K 0.01%
1,900
– –
LCNB icon
115
LCNB Corp
LCNB
$285M
$188K 0.01%
11,500
– –
ADBE icon
116
Adobe
ADBE
$89.5B
$183K 0.01%
524
-10
-2% -$3.4K
SHOP icon
117
Shopify
SHOP
$148B
$181K 0.01%
1,125
– –
EQT icon
118
EQT Corp
EQT
$33.2B
$181K 0.01%
3,375
– –
ADM icon
119
Archer Daniels Midland
ADM
$41.4B
$179K 0.01%
3,115
-300
-9% -$17.9K
TSLA icon
120
Tesla
TSLA
$1.24T
$169K 0.01%
375
– –
KEY icon
121
KeyCorp
KEY
$24.3B
$165K 0.01%
8,000
– –
TFX icon
122
Teleflex
TFX
$5.85B
$162K 0.01%
1,331
-367
-22% -$44.5K
DUK icon
123
Duke Energy
DUK
$102B
$156K 0.01%
1,332
– –
ABNB icon
124
Airbnb
ABNB
$83.7B
$156K 0.01%
1,149
– –
MPC icon
125
Marathon Petroleum
MPC
$90.3B
$153K 0.01%
942
– –
3 4
5
6 7

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q4 2025 Portfolio in Review

As of Q4 2025, Kimelman & Baird held 310 positions worth $1.3B, up 1.7% from $1.28B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Kimelman & Baird's Q4 2025 filing shows 3 new, 19 increased, 69 reduced and 48 closed positions. Its largest new stake was Solstice Advanced Materials: 28,495 shares worth $1.38M. The largest sale was Eli Lilly, an estimated $1.76M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Technology.

  • Kimelman & Baird's largest Q4 2025 buy was Solstice Advanced Materials: 28,495 shares worth $1.38M.
  • Kimelman & Baird added most to Boeing in Q4 2025, an estimated $24M increase.
  • Kimelman & Baird's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $1.76M.
  • Kimelman & Baird fully exited Williams-Sonoma in Q4 2025, selling an estimated $419K.
  • Kimelman & Baird's ten largest holdings make up 44% of its $1.3B portfolio in Q4 2025.
  • Kimelman & Baird opened 3 new positions and closed 48 in Q4 2025.
  • Kimelman & Baird's portfolio value rose 1.7% quarter-over-quarter to $1.3B.

Based on Kimelman & Baird's 13F filing for Q4 2025, filed 6 Feb 2026.